AstraZeneca inks $800M buyout of French biotech to snag phase 3 rare disease drug

By Nick Paul Taylor AstraZeneca is paying $800 million to expand into rare endocrinology, snagging itself a phase 3 candidate through the acquisition of French biotech Amolyt Pharma. The deal features $250 million in milestones tied to a regulatory event. Buying Amolyt will give AstraZeneca control of eneboparatide, a PTHR1 agonist that the biotech moved into phase 3 in June….

Read More

2024 Rare Disease Day: How You Can Make A Difference!

On February 29th, please join us in raising awareness about APS Type 1 as we celebrate the Rare Disease Day! Post messages, photos, videos, or whatever you think best shares your story on social media and add the hashtag #APS1WeAreRare. February 29th is the International Rare Disease Day. This day is dedicated to raising awareness and generating change for the 300…

Read More

Giving Thanks on Giving Tuesday

With a lofty goal of $25,000, the Foundation initiated an email campaign in early November, asking members of the community to activate their networks in giving. The idea behind this approach was to expand our reach and get all families invested in our common mission. Email templates were provided to make the process as easy…

Read More
The Kaitlyn Lovett Memorial Christmas Tournament continues to give back!

The Kaitlyn Lovett Memorial Christmas Tournament continues to give back!

The Kaitlyn Lovett Memorial Christmas Tournament continues to give back!  They raised over $15,000 at last year’s tournament, which supported travel grants to attend our summer symposium for many of our families. Kaitlyn’s mother, Maureen Lovett, shared with the Foundation that it was important to Kaitlyn to positively impact the lives of those with APS…

Read More

Community Spotlight: Payton Ditty

You are not alone in this world, I love you, we all love you and are here to support you through your journey. Payton Ditty Hi! My name’s Payton. I was first diagnosed with APS Type 1 at the age of 7 after an adrenal crisis that lasted weeks. That was the start of my…

Read More

Update on the 5th International Symposium on APS Type 1

We were delighted to see many of you at our 5th International Symposium on APS Type 1. Our symposium brought together APS Type 1 families and medical experts from around the globe. Patients, families, caregivers, researchers, and clinicians had a chance to meet and get to know each other. We are particularly grateful to the doctors…

Read More

Global Genes’ 12th Annual RARE Advocacy Summit

Join board members, Robin Finch and Laura Rivard, at Global Genes’ 12th Annual RARE Advocacy Summit, September 19-21, 2023, in San Diego, California. Each year, Global Genes convenes one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners, and allies at the RARE Advocacy Summit. This is an unparalleled…

Read More